Stomach Cancer Trial, Recruiting NCT06784765 Sponsor: National Research Oncology and Transplantology Center, Kazakhstan Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06784765
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have signed a consent form agreeing to take part in the study
  • People aged between 18 and 70 years old
  • People whose general health and ability to carry out daily activities falls within a certain range, known as ECOG performance status 0–2 (confirm with trial site for what this means in practice)
  • People who have been diagnosed with a specific type of stomach cancer called adenocarcinoma, confirmed by a laboratory tissue test, that has grown into or through the stomach wall and may have spread to nearby lymph nodes, but has not spread to distant parts of the body (classified as T3-4N0-3M0)
  • People whose test results from a keyhole surgical procedure show no cancer cells are present in the fluid around the abdominal organs
  • People who have not previously received chemotherapy or radiotherapy

Who may not be able to join:

  • People whose cancer has spread to distant parts of the body (distant metastases)
  • People whose abdominal fluid test shows cancer cells are present
  • People who have previously received any cancer treatment, including chemotherapy, radiotherapy, or surgery for cancer
  • People with serious other health conditions that would make surgery or chemotherapy unsafe
  • People who are pregnant or currently breastfeeding
  • People with a known allergic reaction or sensitivity to the medications used in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +77014382825

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Research Oncology and Transplantology Center, Kazakhstan
Registry
ClinicalTrials.gov
Start date
15 January 2025
Est. completion
30 December 2026

Where this trial is recruiting

🇰🇿 Kazakhstan

Primary endpoints

Incidence of peritoneal carcinomatosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov